Neoadjuvant Treatment of Breast Cancer

NCT00254592 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Carboplatin
DRUG: Nab-paclitaxel
DRUG: GM-CSF
DRUG: Trastuzumab
DRUG: Bevacizumab

Sponsor

University of California, Irvine